Favorable Outcome of Pregnancy with an Elective Use of Epoprostenol and Sildenafil in Women with Severe Pulmonary Hypertension

Publisher： Karger

E-ISSN： 1421-9751|115|3|205-208

ISSN： 0008-6312

Source： Cardiology, Vol.115, Iss.3, 2010-02, pp. : 205-208

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Serial Hemodynamics and Complications of Pregnancy in Severe Pulmonary Arterial Hypertension

By  

Cardiology, Vol. 109, Iss. 4, 2007-09 ,pp. : 237-240

Karger

Access to resources Recommend Favorite

Pharmacokinetic interactions among imatinib, bosentan and sildenafil, and their clinical implications in severe pulmonary arterial hypertension

By  

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 80, Iss. 1, 2015-07 ,pp. : 75-85

John Wiley & Sons Inc

Access to resources Recommend Favorite

Treatment of Primary Pulmonary Hypertension with Oral Sildenafil

By  

Respiration, Vol. 71, Iss. 2, 2004-03 ,pp. : 192-194

Karger

Access to resources Recommend Favorite

Intermediate- and long-term follow-up of device closure of patent arterial duct with severe pulmonary hypertension: factors predicting outcome

By  

Cardiology in the Young, Vol. 27, Iss. 1, 2016-05 ,pp. : 26-36

Cambridge University Press

Access to resources Recommend Favorite

Cost-minimization analysis of treprostinil vs. epoprostenol as an alternate to oral therapy non-responders for the treatment of pulmonary arterial hypertension

By Narine L.   Hague L. K.   Walker J. H.   Vicente C.   Schilz R.   Desjardins O.   Einarson T. R.   Iskedjian M.  

Current Medical Research and Opinion, Vol. 21, Iss. 12, 2005-12 ,pp. : 2007-2016

Informa Healthcare

Access to resources Recommend Favorite